Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
BACKGROUND: Respiratory syncytial virus (RSV) is the major viral cause of infant and childhood lower respiratory tract disease worldwide. Defining the optimal target product profile (TPP) is complicated due to a wide range of possible vaccine properties, modalities and an incomplete understanding o...
Main Authors: | Pan-Ngum, W, Kinyanjui, T, Kiti, M, Taylor, S, Toussaint, J, Saralamba, S, Van Effelterre, T, Nokes, D, White, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
by: Kinyanjui, T, et al.
Published: (2020) -
Modeling household dynamics on Respiratory Syncytial Virus (RSV)
by: Mahikul, W, et al.
Published: (2019) -
Modeling household dynamics on Respiratory Syncytial Virus (RSV).
by: Wiriya Mahikul, et al.
Published: (2019-01-01) -
Pathobiology of Respiratory Syncytial Virus (RSV)
by: Ralph A. Tripp, et al.
Published: (2020-07-01) -
Respiratory Syncytial Virus (RSV) Update
by: Leonard R. Krilov, et al.
Published: (2022-09-01)